4-(5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)morpholine

Catalog No. :
ACPJRS204
CAS No. :
2223042-19-9
Molecular Formula :
C15H24BNO4
Molecular Weight :
293.17

IUPAC Name:4-(5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)morpholine

4-(5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)morpholine
IUPAC Name4-(5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-yl)morpholine
Molecular FormulaC15H24BNO4
Molecular Weight293.17
SMILESCC(OC(N1CCOCC1)=C2)=C2B3OC(C)(C)C(C)(C)O3
InChI KeyRJKDSXYYJKULKY-UHFFFAOYSA-N
Synonym2-Methyl-5-(morpholino)furan-3-boronic acid pinacol ester;Morpholine, 4-[5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-furanyl]-
CAS No.2223042-19-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPJRS204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPJRS204 route product structure diagram
    ACPJRS2042223042-19-9
Inquiry

2. ACPJRS204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPJRS204 route product structure diagram
    ACPJRS2042223042-19-9
Inquiry

Comments (0)